Category: Zoll Medical Corp.
A study finds that Zoll's LifeVest wearable defibrillator shows promise as a temporary option for patients who must have their ICD removed due to infection and await a new implant.
A new study in the journal Heart Rhythm shows the utility of Zoll Medical's LifeVest wearable defibrillator for a subset of patients who don't start out with the device.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Smith & Nephew buys outs Colombian distributor; Matchmaking for medtech, Greenberg Traurig looks to bring companies together; Zimmer releases post-Biomet merger numbers
Law firm Greenberg Traurig, MassMEDIC and LB Ventures created Medtech Partnering Day with an eye on putting start-ups and medtech titans together in the same room.
Editors note: This article originally ran Jan. 21, but the event was postponed due to snow in the Boston area. Greenberg Traurig is slated to host the next MedTech Partnering Day March 13 in its Boston office. Contact firstname.lastname@example.org by March 11 to participate.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: U.K. regulators OK $2B Steris merger with Synergy Health; Hospira beats earnings forecasts for Q4, 2014; U.K. regulators pass on probe of Zoll Medical's Philips InnerCool buy; William Demant in talks to buy French hearing aid retailer Audika
Zoll Medical Corp.
, Costco Wholesale Corp.
, Hospira Inc.
, Pfizer Inc.
, Royal Philips
, Sonova Holding AG
, Steris Corp.
, Synergy Health
, U.K. Competition and Markets Authority
, William Demant Holding
The U.K.'s Competition & Markets Authority decides not to open an investigation into Zoll Medical's acquisition of the InnerCool business from Royal Philips.
MassDevice.com takes a look at how the numbers thrown around about job losses from the medical device tax are calculated.
For going on 5 years now, opponents on both sides of the fight over the medical device tax have engaged in a rhetorical war about the number of jobs that will be lost to the levy.
The FDA says it will require automated external defibrillators to undergo its strict pre-market approval process.